India's Glenmark to study potential COVID-19 drug combination
Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment.
from Reuters: Health News https://reut.rs/3glXMHJ
https://bit.ly/2zwRqiM